vs

Side-by-side financial comparison of JBG SMITH Properties (JBGS) and Varex Imaging Corp (VREX). Click either name above to swap in a different company.

Varex Imaging Corp is the larger business by last-quarter revenue ($209.6M vs $127.6M, roughly 1.6× JBG SMITH Properties). Varex Imaging Corp runs the higher net margin — 1.1% vs -18.1%, a 19.2% gap on every dollar of revenue. On growth, JBG SMITH Properties posted the faster year-over-year revenue change (5.7% vs 4.9%). Over the past eight quarters, Varex Imaging Corp's revenue compounded faster (0.8% CAGR vs -2.9%).

JBG SMITH Properties is a publicly traded real estate investment trust based in Bethesda, Maryland.

Varex Imaging Corp is a global supplier of advanced imaging components and solutions, including X-ray tubes, digital flat panel detectors, and image processing software. Its products serve medical imaging, radiation oncology, and industrial non-destructive testing segments, with customers across key global markets.

JBGS vs VREX — Head-to-Head

Bigger by revenue
VREX
VREX
1.6× larger
VREX
$209.6M
$127.6M
JBGS
Growing faster (revenue YoY)
JBGS
JBGS
+0.8% gap
JBGS
5.7%
4.9%
VREX
Higher net margin
VREX
VREX
19.2% more per $
VREX
1.1%
-18.1%
JBGS
Faster 2-yr revenue CAGR
VREX
VREX
Annualised
VREX
0.8%
-2.9%
JBGS

Income Statement — Q1 FY2026 vs Q1 FY2026

Metric
JBGS
JBGS
VREX
VREX
Revenue
$127.6M
$209.6M
Net Profit
$-23.0M
$2.3M
Gross Margin
33.3%
Operating Margin
7.3%
Net Margin
-18.1%
1.1%
Revenue YoY
5.7%
4.9%
Net Profit YoY
57.1%
866.7%
EPS (diluted)
$-0.32
$0.05

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
JBGS
JBGS
VREX
VREX
Q1 26
$127.6M
$209.6M
Q4 25
$127.6M
$228.9M
Q3 25
$123.9M
$203.0M
Q2 25
$126.5M
$212.9M
Q1 25
$120.7M
$199.8M
Q4 24
$130.8M
Q3 24
$136.0M
$205.7M
Q2 24
$135.3M
$209.1M
Net Profit
JBGS
JBGS
VREX
VREX
Q1 26
$-23.0M
$2.3M
Q4 25
$-45.5M
$12.2M
Q3 25
$-28.6M
$-89.1M
Q2 25
$-19.2M
$6.9M
Q1 25
$-45.7M
$-300.0K
Q4 24
$-59.9M
Q3 24
$-27.0M
$-51.1M
Q2 24
$-24.4M
$1.4M
Gross Margin
JBGS
JBGS
VREX
VREX
Q1 26
33.3%
Q4 25
34.0%
Q3 25
33.3%
Q2 25
36.0%
Q1 25
34.3%
Q4 24
Q3 24
32.6%
Q2 24
32.0%
Operating Margin
JBGS
JBGS
VREX
VREX
Q1 26
7.3%
Q4 25
-47.5%
8.6%
Q3 25
-27.5%
-39.8%
Q2 25
-18.4%
10.4%
Q1 25
-44.7%
5.6%
Q4 24
-53.6%
Q3 24
-22.4%
5.3%
Q2 24
-24.3%
4.4%
Net Margin
JBGS
JBGS
VREX
VREX
Q1 26
-18.1%
1.1%
Q4 25
-35.7%
5.3%
Q3 25
-23.1%
-43.9%
Q2 25
-15.2%
3.2%
Q1 25
-37.9%
-0.2%
Q4 24
-45.8%
Q3 24
-19.8%
-24.8%
Q2 24
-18.0%
0.7%
EPS (diluted)
JBGS
JBGS
VREX
VREX
Q1 26
$-0.32
$0.05
Q4 25
$-0.76
$0.29
Q3 25
$-0.48
$-2.15
Q2 25
$-0.29
$0.17
Q1 25
$-0.56
$-0.01
Q4 24
$-0.70
Q3 24
$-0.32
$-1.25
Q2 24
$-0.27
$0.03

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
JBGS
JBGS
VREX
VREX
Cash + ST InvestmentsLiquidity on hand
$125.6M
Total DebtLower is stronger
$367.6M
Stockholders' EquityBook value
$476.9M
Total Assets
$4.3B
$1.1B
Debt / EquityLower = less leverage
0.77×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
JBGS
JBGS
VREX
VREX
Q1 26
$125.6M
Q4 25
$75.3M
$155.1M
Q3 25
$64.4M
$152.6M
Q2 25
$61.4M
$223.0M
Q1 25
$81.3M
$212.6M
Q4 24
$145.8M
Q3 24
$137.0M
$200.5M
Q2 24
$163.5M
$190.0M
Total Debt
JBGS
JBGS
VREX
VREX
Q1 26
$367.6M
Q4 25
$367.5M
Q3 25
$367.5M
Q2 25
$567.2M
Q1 25
$567.0M
Q4 24
Q3 24
$443.4M
Q2 24
$443.1M
Stockholders' Equity
JBGS
JBGS
VREX
VREX
Q1 26
$476.9M
Q4 25
$1.2B
$472.6M
Q3 25
$1.2B
$455.3M
Q2 25
$1.3B
$549.7M
Q1 25
$1.6B
$540.2M
Q4 24
$1.8B
Q3 24
$1.9B
$529.1M
Q2 24
$2.0B
$581.2M
Total Assets
JBGS
JBGS
VREX
VREX
Q1 26
$4.3B
$1.1B
Q4 25
$4.4B
$1.1B
Q3 25
$4.4B
$1.1B
Q2 25
$4.5B
$1.4B
Q1 25
$4.7B
$1.3B
Q4 24
$5.0B
Q3 24
$5.2B
$1.2B
Q2 24
$5.3B
$1.3B
Debt / Equity
JBGS
JBGS
VREX
VREX
Q1 26
0.77×
Q4 25
0.78×
Q3 25
0.81×
Q2 25
1.03×
Q1 25
1.05×
Q4 24
Q3 24
0.84×
Q2 24
0.76×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
JBGS
JBGS
VREX
VREX
Operating Cash FlowLast quarter
$-16.1M
Free Cash FlowOCF − Capex
$-26.8M
FCF MarginFCF / Revenue
-12.8%
Capex IntensityCapex / Revenue
5.1%
Cash ConversionOCF / Net Profit
-7.00×
TTM Free Cash FlowTrailing 4 quarters
$-13.3M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
JBGS
JBGS
VREX
VREX
Q1 26
$-16.1M
Q4 25
$73.3M
$7.9M
Q3 25
$8.9M
$7.7M
Q2 25
$18.8M
$16.6M
Q1 25
$12.9M
$9.5M
Q4 24
$129.4M
Q3 24
$26.4M
$25.9M
Q2 24
$23.8M
$8.0M
Free Cash Flow
JBGS
JBGS
VREX
VREX
Q1 26
$-26.8M
Q4 25
$2.3M
Q3 25
$1.4M
Q2 25
$9.8M
Q1 25
$5.3M
Q4 24
Q3 24
$19.9M
Q2 24
$3.3M
FCF Margin
JBGS
JBGS
VREX
VREX
Q1 26
-12.8%
Q4 25
1.0%
Q3 25
0.7%
Q2 25
4.6%
Q1 25
2.7%
Q4 24
Q3 24
9.7%
Q2 24
1.6%
Capex Intensity
JBGS
JBGS
VREX
VREX
Q1 26
5.1%
Q4 25
2.4%
Q3 25
3.1%
Q2 25
3.2%
Q1 25
2.1%
Q4 24
Q3 24
2.9%
Q2 24
2.2%
Cash Conversion
JBGS
JBGS
VREX
VREX
Q1 26
-7.00×
Q4 25
0.65×
Q3 25
Q2 25
2.41×
Q1 25
Q4 24
Q3 24
Q2 24
5.71×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

JBGS
JBGS

Property rental$105.9M83%
Third-party real estate services, including reimbursements$17.2M13%
Other revenue$4.5M4%

VREX
VREX

Medical Segment$144.8M69%
Industrial Segment$64.8M31%

Related Comparisons